Single dose of LSD provides immediate and sustained anxiety relief
According to the results of a new study conducted by MindMed, just 100 micrograms of the hallucinogen can halve anxiety within weeks. As a result of this successful clinical trial, the US Food and Drug Administration has granted breakthrough therapy status to the biopharmaceutical company’s proprietary treatment.
Following decades of demonisation and criminalisation, psychedelic drugs are being proved to have profound implications for a field that’s seen few pharmacological advancements since the 60s.
Namely the treatment of intractable conditions such as depression, PTSD, and addiction, which time and time again these mind-altering substances have shown genuine promise in alleviating the symptoms of.
Now more than ever before — amid a mental health crisis that has care services bursting at the seams — there’s a great body of evidence regarding their enormous medical potential as well as a recognition that we are in dire need of new therapeutic tools.
Thankfully, the psychedelic renaissance is well underway, despite the complications the status of…